These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 8757513)
1. A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: best outcome in girls, infants, and children with Down's syndrome. Nordic Society of Paediatric Haematology and Oncology (NOPHO). Lie SO; Jonmundsson G; Mellander L; Siimes MA; Yssing M; Gustafsson G Br J Haematol; 1996 Jul; 94(1):82-8. PubMed ID: 8757513 [TBL] [Abstract][Full Text] [Related]
2. Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down's syndrome: results of NOPHO-AML trials. Lie SO; Abrahamsson J; Clausen N; Forestier E; Hasle H; Hovi L; Jonmundsson G; Mellander L; Gustafsson G Br J Haematol; 2003 Jul; 122(2):217-25. PubMed ID: 12846889 [TBL] [Abstract][Full Text] [Related]
3. Acute leukaemia in children with Down syndrome: a population-based Nordic study. Zeller B; Gustafsson G; Forestier E; Abrahamsson J; Clausen N; Heldrup J; Hovi L; Jonmundsson G; Lie SO; Glomstein A; Hasle H; Br J Haematol; 2005 Mar; 128(6):797-804. PubMed ID: 15755283 [TBL] [Abstract][Full Text] [Related]
4. Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000. Ravindranath Y; Chang M; Steuber CP; Becton D; Dahl G; Civin C; Camitta B; Carroll A; Raimondi SC; Weinstein HJ; Leukemia; 2005 Dec; 19(12):2101-16. PubMed ID: 16136167 [TBL] [Abstract][Full Text] [Related]
5. Optimal treatment intensity in children with Down syndrome and myeloid leukaemia: data from 56 children treated on NOPHO-AML protocols and a review of the literature. Abildgaard L; Ellebaek E; Gustafsson G; Abrahamsson J; Hovi L; Jonmundsson G; Zeller B; Hasle H Ann Hematol; 2006 May; 85(5):275-80. PubMed ID: 16518605 [TBL] [Abstract][Full Text] [Related]
6. Long-term results in children with AML: NOPHO-AML Study Group--report of three consecutive trials. Lie SO; Abrahamsson J; Clausen N; Forestier E; Hasle H; Hovi L; Jonmundsson G; Mellander L; Siimes MA; Yssing M; Zeller B; Gustafsson G; ; Leukemia; 2005 Dec; 19(12):2090-100. PubMed ID: 16304571 [TBL] [Abstract][Full Text] [Related]
7. Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non-high-risk patients: the Nordic experience of 2648 patients diagnosed between 1981 and 1996. Nordic Society of Paediatric Haematology and Oncology (NOPHO). Gustafsson G; Kreuger A; Clausen N; Garwicz S; Kristinsson J; Lie SO; Moe PJ; Perkkiö M; Yssing M; Saarinen-Pihkala UM Acta Paediatr; 1998 Nov; 87(11):1151-61. PubMed ID: 9846917 [TBL] [Abstract][Full Text] [Related]
8. Improved outcome of acute myeloid leukaemia in Down's syndrome. Craze JL; Harrison G; Wheatley K; Hann IM; Chessells JM Arch Dis Child; 1999 Jul; 81(1):32-7. PubMed ID: 10373130 [TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of karyotypic findings in childhood acute lymphoblastic leukaemia: a Nordic series comparing two treatment periods. For the Nordic Society of Paediatric Haematology and Oncology (NOPHO) Leukaemia Cytogenetic Study Group. Forestier E; Johansson B; Gustafsson G; Borgström G; Kerndrup G; Johannsson J; Heim S Br J Haematol; 2000 Jul; 110(1):147-53. PubMed ID: 10930992 [TBL] [Abstract][Full Text] [Related]
11. Paediatric B-cell precursor acute lymphoblastic leukaemia with t(1;19)(q23;p13): clinical and cytogenetic characteristics of 47 cases from the Nordic countries treated according to NOPHO protocols. Andersen MK; Autio K; Barbany G; Borgström G; Cavelier L; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Johansson B; Kjeldsen E; Nordgren A; Palmqvist L; Forestier E Br J Haematol; 2011 Oct; 155(2):235-43. PubMed ID: 21902680 [TBL] [Abstract][Full Text] [Related]
12. Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO). Gustafsson G; Schmiegelow K; Forestier E; Clausen N; Glomstein A; Jonmundsson G; Mellander L; Mäkipernaa A; Nygaard R; Saarinen-Pihkala UM Leukemia; 2000 Dec; 14(12):2267-75. PubMed ID: 11187918 [TBL] [Abstract][Full Text] [Related]
13. Cerebral sinus venous thromboses in children with acute lymphoblastic leukaemia - a multicentre study from the Nordic Society of Paediatric Haematology and Oncology. Ranta S; Tuckuviene R; Mäkipernaa A; Albertsen BK; Frisk T; Tedgård U; Jónsson ÓG; Pruunsild K; Gretenkort Andersson N; Winther Gunnes M; Saulyte Trakymiene S; Frandsen T; Heyman M; Ruud E; Helgestad J Br J Haematol; 2015 Feb; 168(4):547-52. PubMed ID: 25288392 [TBL] [Abstract][Full Text] [Related]
15. Complex and monosomal karyotype are distinct cytogenetic entities with an adverse prognostic impact in paediatric acute myeloid leukaemia. A NOPHO-DBH-AML study. Bager N; Juul-Dam KL; Sandahl JD; Abrahamsson J; Beverloo B; de Bont ESJM; Ha SY; Jahnukainen K; Jónsson ÓG; Kaspers GL; Kovalova Z; Lausen B; De Moerloose B; Noren-Nyström U; Palle J; Saks K; Zeller B; Kjeldsen E; Hasle H Br J Haematol; 2018 Nov; 183(4):618-628. PubMed ID: 30406946 [TBL] [Abstract][Full Text] [Related]
16. Age- and sex-specific incidence of childhood leukemia by immunophenotype in the Nordic countries. Hjalgrim LL; Rostgaard K; Schmiegelow K; Söderhäll S; Kolmannskog S; Vettenranta K; Kristinsson J; Clausen N; Melbye M; Hjalgrim H; Gustafsson G J Natl Cancer Inst; 2003 Oct; 95(20):1539-44. PubMed ID: 14559876 [TBL] [Abstract][Full Text] [Related]
17. Therapy reduction in patients with Down syndrome and myeloid leukemia: the international ML-DS 2006 trial. Uffmann M; Rasche M; Zimmermann M; von Neuhoff C; Creutzig U; Dworzak M; Scheffers L; Hasle H; Zwaan CM; Reinhardt D; Klusmann JH Blood; 2017 Jun; 129(25):3314-3321. PubMed ID: 28400376 [TBL] [Abstract][Full Text] [Related]
18. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial. Nielsen SN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Hjalgrim LL; Schmiegelow K Lancet Oncol; 2017 Apr; 18(4):515-524. PubMed ID: 28258828 [TBL] [Abstract][Full Text] [Related]
19. Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003. Molgaard-Hansen L; Möttönen M; Glosli H; Jónmundsson GK; Abrahamsson J; Hasle H; Br J Haematol; 2010 Dec; 151(5):447-59. PubMed ID: 20955398 [TBL] [Abstract][Full Text] [Related]
20. Hyperleucocytosis in paediatric acute myeloid leukaemia - the challenge of white blood cell counts above 200 × 10 Zeller B; Glosli H; Forestier E; Ha SY; Jahnukainen K; Jónsson ÓG; Lausen B; Palle J; Hasle H; Abrahamsson J; Br J Haematol; 2017 Aug; 178(3):448-456. PubMed ID: 28542715 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]